Comment on "Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival".

Authors

Zoha Fatima, Shahran Choudhary, Huzaifa Zafar Choudhary

Published in

Breast cancer research and treatment. Volume 220. Issue 1. Oct 20, 2026. Epub Oct 20, 2026.

Abstract

Podany et al. examined associations between Area Deprivation Index (ADI) and tumor genomics, PI3K inhibitor use, and survival in 1,127 patients with metastatic breast cancer. While their multi-institutional, genomically annotated dataset is a valuable contribution, several methodological issues warrant scrutiny.
We critically reviewed the study's statistical approach, focusing on multiple-comparison handling, potential confounding from ctDNA shedding variability, and the reliability of subgroup survival estimates.
Key findings (TP53, AKT1, overall survival, PI3Ki-use disparity, and Black patient survival disadvantage) relied on borderline p-values from uncorrected multiple comparisons across 19 supplementary tables. Lower visceral, nodal, and soft-tissue metastasis rates in high-deprivation patients suggest reduced ctDNA shedding, which could confound reported mutation-frequency differences, particularly for AKT1. The AKT1 subgroup hazard ratio (6.27) derived from roughly five events, far below recommended events-per-variable thresholds, raising concerns about estimate stability.
Addressing multiplicity correction, ctDNA shedding assessment, and transparent event-count reporting would strengthen confidence in the study's conclusions and better inform future prospective research.

PMID:
42901996
Bibliographic data and abstract were imported from PubMed on 21 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.